Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain gene transfer tested for Parkinson's: is it safe?

NCT ID NCT05603312

First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 23 times

Summary

This early-stage study tested a gene therapy for Parkinson's disease. The treatment involved delivering a gene to a specific part of the brain to help control movement. The main goal was to check if the procedure is safe and tolerable for people with Parkinson's. Only 14 participants were enrolled, and the study was completed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Columbia University Irving Medical Center

    New York, New York, 10032, United States

  • Henry Ford West Bloomfield Hospital

    West Bloomfield, Michigan, 48322, United States

  • Thomas Jefferson University

    Philadelphia, Pennsylvania, 19107, United States

  • Weill Cornell Medicine

    New York, New York, 10021, United States

  • West Virginia University

    Morgantown, West Virginia, 26506, United States

  • Yale University - Yale New Haven Hospital

    New Haven, Connecticut, 06510, United States

Conditions

Explore the condition pages connected to this study.